Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

2.670 +0.070 (+2.69%)
Streaming Delayed Price Updated: 3:42 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,659
Open 2.570
Bid (Size) 2.450 (1)
Ask (Size) 2.750 (1)
Prev. Close 2.600
Today's Range 2.410 - 2.670
52wk Range 2.360 - 60.48
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Performance

YTD
-74.6%
-74.6%
1 Month
-23.5%
-23.5%
3 Month
-74.6%
-74.6%
6 Month
-79.9%
-79.9%
1 Year
-93.6%
-93.6%

More News

Read More
Traders are paying attention to the gapping stocks in Monday's session.
Via Chartmill
Which stocks are moving before the opening bell on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
From Revelation Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference
From Revelation Biosciences, Inc.
Via Business Wire
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024
From Revelation Biosciences, Inc.
Via Business Wire
Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients
From Revelation Biosciences, Inc.
Via Business Wire
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
From Revelation Biosciences, Inc.
Via Business Wire
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Via Chartmill
These stocks are moving in today's session
Via Chartmill
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
From Revelation Biosciences, Inc.
Via Business Wire
Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
From Revelation Biosciences, Inc.
Via Business Wire
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
From Revelation Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Revelation Biosciences (REVB) Stock Is Down 38%
Via Benzinga
Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
From Revelation Biosciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Revelation Biosciences, Inc. - Common Stock publicly traded?
Yes, Revelation Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Revelation Biosciences, Inc. - Common Stock trade on?
Revelation Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revelation Biosciences, Inc. - Common Stock?
The ticker symbol for Revelation Biosciences, Inc. - Common Stock is REVB on the Nasdaq Stock Market
What is the current price of Revelation Biosciences, Inc. - Common Stock?
The current price of Revelation Biosciences, Inc. - Common Stock is 2.670
When was Revelation Biosciences, Inc. - Common Stock last traded?
The last trade of Revelation Biosciences, Inc. - Common Stock was at 04/02/25 03:42 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.